Dr Cornes is an oncologist in Bristol. He is part of the steering group for the European School of Oncology Working Party on the Access to Innovation in Cancer Treatment, and he has run biosimilar medicine education sessions for a number of large professional organisations in Europe. In the US, Dr Cornes was part of the team that presented evidence for the first successful biosimilar medicine to the Oncology Drugs Advisory Committee of the FDA. At a local level, Dr Cornes has been an advisor to the TGA and PBS on biosimilar medicines in Australia.